SAEs · health problem or population
Summary of findings table ‐ Cannabis showed no clear difference in SAEs: number of participants with SAEs ( compared with placebo (low certainty).
1 finding from 1 review
Specific adverse events:nervous system disorder · health problem or population
Summary of findings table ‐ Cannabis may leads to higher specific AEs:number of participants reporting nervous system… compared with placebo (low certainty).
1 finding from 1 review
Adverse events: psychological disorders · health problem or population
Summary of findings table ‐ Cannabis may leads to higher specific AEs: number of participants reporting psychiatric disorders ( compared with placebo (low certainty).
1 finding from 1 review
Specific AEs: number of participants reporting drug tolerance ( · health problem or population
It is very uncertain whether summary of findings table ‐ Cannabis changes specific AEs: number of participants reporting drug tolerance ( compared with placebo (very low certainty).
1 finding from 1 review
Stroke · preventing early recurrence after ischaemic stroke or TIA
Dual probably leads to lower stroke compared with one antiplatelet agent (moderate certainty).
1 finding from 1 review
Deaths due to vascular events · preventing early recurrence after ischaemic stroke or TIA
Dual showed no clear difference in vascular death compared with one antiplatelet agent (moderate certainty).
1 finding from 1 review
Myocardial infarction · preventing early recurrence after ischaemic stroke or TIA
Dual showed no clear difference in myocardial infarction compared with one antiplatelet agent (high certainty).
1 finding from 1 review
Stroke, myocardial infarction, or vascular death · preventing early recurrence after ischaemic stroke or TIA
Dual probably leads to lower stroke, myocardial infarction, or vascular death compared with one antiplatelet agent (moderate certainty).
1 finding from 1 review
Intracranial haemorrhage · preventing early recurrence after ischaemic stroke or TIA
Dual showed no clear difference in intracranial haemorrhage compared with one antiplatelet agent (low certainty).
1 finding from 1 review
Extracranial haemorrhage · preventing early recurrence after ischaemic stroke or TIA
Dual leads to higher extracranial haemorrhage compared with one antiplatelet agent (high certainty).
1 finding from 1 review
Ischaemic stroke · preventing early recurrence after ischaemic stroke or TIA
Dual leads to lower ischaemic stroke compared with one antiplatelet agent (high certainty).
1 finding from 1 review
Outcomes at ≥ 3 months · preventing early recurrence after ischaemic stroke or TIA
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Medication‐taking ability · older patients using at least 4 regular prescription medications (and/or their carers)
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Health‐related quality of life · older patients using at least 4 regular prescription medications (and/or their carers)
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Intervention not reported
ED/Hospital admissions · older patients using at least 4 regular prescription medications (and/or their carers)
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Intervention not reported
Mortality · older patients using at least 4 regular prescription medications (and/or their carers)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Medication‐taking ability · older patients using at least 4 regular prescription medications (and/or their carers)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Medication adherence (dichotomous) · older patients using at least 4 regular prescription medications (and/or their carers)
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Medication adherence (continuous) · older patients using at least 4 regular prescription medications (and/or their carers)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Health‐related quality of life · older patients using at least 4 regular prescription medications (and/or their carers)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low